Norway vs Singapore: Immunization, HepB3
Norway
96.0%
in 2024
Singapore
96.0%
in 2024
Norway rank
42nd
Singapore rank
42nd
Immunization, HepB3 over time
- Norway
- Singapore
How they compare
Norway currently reports 96.0% against 96.0% in Singapore, a difference of 0.0%.
Across all 6 years both countries report, Singapore has been ahead every year.
Norway ranks 42nd and Singapore ranks 42nd of 188 countries.
Singapore has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 96.0% | 97.0% | 1.0% | Singapore |
| 2020s | 96.2% | 96.6% | 0.4% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Norway or Singapore?
- Norway, at 96.0% against 96.0% in Singapore as of 2024.
- What is the difference in immunization, hepb3 between Norway and Singapore?
- 0.0%, with Norway ahead.
- How many years of comparable data are there for Norway and Singapore?
- 6 years are reported by both, from 2019 to 2024.
- How do Norway and Singapore rank globally for immunization, hepb3?
- Norway ranks 42nd and Singapore ranks 42nd of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.